.25 mg semaglutide syringe Pre-Filled Injection 0.25mg Semaglutide .25mg - 4 injections

Our goal is to ensure that you receive safe, effective, and ongoing support throughout your weight loss journey

55,58 However, postmarketing data on exenatide indicate an increase in INR, which is sometimes associated with bleeding events, highlighting the need for close INR monitoring after GLP-1 RA treatment

doi: 10.1017/jns.2014.71

I no longer feel the urge to chew my nails or pick at my skin

Sources Lilly - What to know about retatrutide (updated March 2026) Lilly - TRIUMPH-4 Phase 3 retatrutide results on weight loss (December 11, 2025) Lilly - TRANSCEND-T2D-1 Phase 3 retatrutide results in type 2 diabetes (March 19, 2026) Lilly - TRIUMPH Phase 3 trial listing Jastreboff AM et al